Abstract: Of the present technology are SERPIN peptide derivatives, methods of making the same, and uses of the same for treating various conditions associated with LRP1 mediation.
Type:
Application
Filed:
April 27, 2023
Publication date:
November 20, 2025
Applicant:
SERPIN PHARMA, LLC
Inventors:
Cohava Gelber, Cyrille Gineste, Dana Austin
Abstract: Disclosed herein are SERPIN peptides, and analogues and derivatives thereof, and uses of the same for treating various conditions associated with LRP1 mediation.